TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH)
(“Aleafia Health” or the “Company”), is providing an update regarding a press release (the
“Press Release”) issued by an unrelated third party.
A Press Release issued by Aura Health Inc. (“Aura”) entitled “With a Strategic Investment by
Aleafia Health, Aura Health Announces Increase to Previously Announced Brokered Subscription Receipt Financing to $7.26 Million”
came to the attention of the Company.
Although the Company was solicited to participate in Aura’s private placement, Aleafia Health is not negotiating a
subscription agreement, nor has the Company had the opportunity to perform due diligence or submit the participation to the TSX
Venture Exchange for acceptance. At this time Aleafia Health is not participating in the private placement.
For Investor & Media Relations, please contact:
Nicholas Bergamini, VP, Public Affairs
416-860-5665
IR@AleafiaInc.com
About Aleafia Health:
Aleafia Heath, a vertically integrated, national cannabis company, operates major medical clinic, cannabis cultivation and
R&D divisions. A federally licensed producer and vendor of cannabis, the company has a planned and fully-funded annual
production capacity of 98,000 kg of dried cannabis flower.
The Company operates medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The
company is highly differentiated, maintaining the largest medical cannabis dataset in the world, which it used to develop unique,
proprietary cannabis products and treatment methods.
Aleafia Health is committed to creating sustainable shareholder value and has been named the top performing company of the year
by the TSX Venture Exchange.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
Exchange) accepts responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and information that are based on the beliefs of management and reflect
the Company's current expectations. When used in this press release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and information.
The forward-looking statements and information in this press release includes information relating to the implementation of
Aleafia Health's business plan. Such statements and information reflect the current view of the Company with respect to risks and
uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and
information.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements, or other future events, to be materially different from any future results,
performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the
following risks: risks associated with the implementation of Aleafia Health's business plan and matters relating thereto, risks
associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key
personnel, the potential for conflicts of interest among certain officers or directors, and the volatility of the Company's common
share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that
statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and
opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking
statements.
